---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-026286"
form_type: "8-K"
ticker: "DMAC"
cik: "0001401040"
company_name: "DiaMedica Therapeutics Inc."
filed_at: "2025-08-12T23:59:59+00:00"
generated_at: "2026-05-17T14:22:38.566698+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# DiaMedica enters $100M ATM equity distribution agreement with TD Cowen

## Summary
- Up to $100M in common shares may be sold through TD Cowen as sales agent.
- TD Cowen earns up to 3.0% commission on gross proceeds from ATM sales.
- Sales cannot occur until the related Form S-3 shelf registration is declared effective.
- Proceeds use not specified; agreement includes customary indemnification provisions.

## SEC filing metadata
- accession: 0001437749-25-026286
- form_type: 8-K
- ticker: DMAC
- cik: 0001401040
- company_name: DiaMedica Therapeutics Inc.
- filed_at: 2025-08-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401040/000143774925026286/0001437749-25-026286-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401040/000143774925026286/dmtp20250812_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-026286
- JSON: https://secwatch.observer/filing/0001437749-25-026286.json
- Plain text: https://secwatch.observer/filing/0001437749-25-026286.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.